SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $133,000 | -0.7% | 27,142 | -16.3% | 0.01% | -13.3% |
Q2 2022 | $134,000 | -70.5% | 32,423 | -58.6% | 0.02% | -72.2% |
Q1 2022 | $455,000 | +78.4% | 78,376 | +267.4% | 0.05% | +107.7% |
Q2 2021 | $255,000 | +44.9% | 21,331 | +8.7% | 0.03% | 0.0% |
Q2 2020 | $176,000 | -69.3% | 19,628 | -51.4% | 0.03% | -69.8% |
Q2 2018 | $573,000 | +102.5% | 40,384 | +171.0% | 0.09% | +104.8% |
Q1 2018 | $283,000 | -70.3% | 14,901 | -76.5% | 0.04% | -72.9% |
Q3 2017 | $953,000 | +1412.7% | 63,519 | +421.6% | 0.16% | +933.3% |
Q1 2017 | $63,000 | – | 12,177 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |